HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ivo Abraham Selected Research

Filgrastim (Neupogen)

1/2020Febrile neutropenia hospitalization due to pegfilgrastim on-body injector failure compared to single-injection pegfilgrastim and daily injections with reference and biosimilar filgrastim: US cost simulation for lung cancer and non-Hodgkin lymphoma.
6/2019Outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (Zarzio®) initiated "same-day" (< 24 h), "per-guidelines" (24-72 h), and "late" (> 72 h): findings from the MONITOR-GCSF study.
3/2019Chemotherapy-induced neutropenia/febrile neutropenia prophylaxis with biosimilar filgrastim in solid tumors versus hematological malignancies: MONITOR-GCSF study.
1/2018Reply: Cost-efficiency analyses for the US of biosimilar filgrastim-sndz, reference filgrastim, pegfilgrastim, and pegfilgrastim with on-body injector in the prophylaxis of chemotherapy-induced (febrile) neutropenia.
10/2017Cost-efficiency analyses for the US of biosimilar filgrastim-sndz, reference filgrastim, pegfilgrastim, and pegfilgrastim with on-body injector in the prophylaxis of chemotherapy-induced (febrile) neutropenia.
10/2017Expanded access to cancer treatments from conversion to neutropenia prophylaxis with biosimilar filgrastim-sndz.
1/2017Chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim in elderly versus non-elderly cancer patients: Patterns, outcomes, and determinants (MONITOR-GCSF study).
1/2017Over- and under-prophylaxis for chemotherapy-induced (febrile) neutropenia relative to evidence-based guidelines is associated with differences in outcomes: findings from the MONITOR-GCSF study.
2/2016Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study).
1/2016Erratum to: Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study).
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ivo Abraham Research Topics

Disease

31Neoplasms (Cancer)
01/2021 - 01/2008
14Chemotherapy-Induced Febrile Neutropenia
06/2022 - 03/2011
12Febrile Neutropenia
04/2022 - 03/2011
9Neutropenia
06/2022 - 01/2017
9Anemia
04/2022 - 01/2008
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2020 - 10/2019
7Pancreatic Neoplasms (Pancreatic Cancer)
11/2021 - 01/2017
6Breast Neoplasms (Breast Cancer)
04/2022 - 11/2015
6Melanoma (Melanoma, Malignant)
12/2021 - 01/2016
6Hypertension (High Blood Pressure)
01/2021 - 05/2009
5COVID-19
05/2022 - 01/2021
4Multiple Myeloma
06/2022 - 03/2011
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2021 - 05/2009
4Lymphoma (Lymphomas)
09/2021 - 11/2015
4Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 06/2011
4Asthma (Bronchial Asthma)
01/2021 - 09/2017
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
10/2022 - 08/2021
3Cognitive Dysfunction
04/2022 - 01/2020
3Thrombocytopenia (Thrombopenia)
04/2022 - 12/2016
3Macular Degeneration (Age-Related Maculopathy)
01/2020 - 01/2013
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2017 - 06/2011
2Lung Neoplasms (Lung Cancer)
06/2022 - 01/2020
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2022 - 11/2021
2Pain (Aches)
04/2022 - 02/2022
2Intervertebral Disc Displacement (Herniated Disc)
04/2022 - 02/2022
2Spinal Stenosis (Stenosis, Spinal)
04/2022 - 02/2022
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2021 - 01/2021
2Hypothyroidism
04/2021 - 01/2020
2Critical Illness (Critically Ill)
01/2021 - 10/2020
2Colitis
01/2021 - 01/2020
2Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2021 - 01/2020
2Fatigue
01/2020 - 01/2017
2Diarrhea
01/2020 - 01/2017
2Prostatic Neoplasms (Prostate Cancer)
11/2019 - 02/2019
2Adenocarcinoma
10/2019 - 04/2017
2Type 2 Diabetes Mellitus (MODY)
06/2019 - 12/2016
2Colorectal Neoplasms (Colorectal Cancer)
03/2019 - 11/2018
2Hematologic Neoplasms (Hematological Malignancy)
03/2019 - 01/2017
2Urticaria (Hives)
01/2019 - 01/2018
2Hemorrhage
01/2017 - 12/2016
2Chronic Disease (Chronic Diseases)
01/2017 - 01/2017
2Chronic Kidney Failure (Chronic Renal Failure)
12/2014 - 11/2012

Drug/Important Bio-Agent (IBA)

25Biosimilar PharmaceuticalsIBA
01/2022 - 03/2011
14Filgrastim (Neupogen)FDA Link
01/2020 - 03/2011
13pegfilgrastim (Neulasta)FDA Link
06/2022 - 06/2012
7osimertinibIBA
11/2020 - 11/2020
6IpilimumabIBA
12/2021 - 01/2016
6Omalizumab (Xolair)FDA Link
01/2021 - 09/2017
5GemcitabineFDA Link
11/2021 - 01/2017
5Granulocyte Colony-Stimulating Factor (G-CSF)IBA
08/2021 - 03/2011
5pembrolizumabIBA
04/2021 - 10/2019
5HematinicsIBA
04/2013 - 02/2008
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022 - 01/2020
4Immune Checkpoint InhibitorsIBA
12/2021 - 01/2016
4Imatinib Mesylate (Gleevec)FDA Link
12/2021 - 05/2009
4130-nm albumin-bound paclitaxelIBA
11/2021 - 04/2017
4folfirinoxIBA
11/2021 - 04/2017
4Rituximab (Mabthera)FDA Link
11/2021 - 04/2015
4NivolumabIBA
04/2021 - 10/2019
4Valsartan (Vals)FDA Link
01/2021 - 05/2009
4Ranibizumab (Lucentis)FDA Link
01/2020 - 01/2013
3Pharmaceutical PreparationsIBA
06/2022 - 12/2016
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 01/2020
3Trastuzumab (Herceptin)FDA Link
01/2022 - 04/2015
3Prednisone (Sone)FDA LinkGeneric
09/2021 - 11/2019
3Anti-Bacterial Agents (Antibiotics)IBA
02/2021 - 01/2017
3Heparin (Liquaemin)FDA LinkGeneric
06/2019 - 12/2016
3Epoetin Alfa (Epogen)FDA Link
01/2018 - 01/2014
3IronIBA
01/2017 - 06/2011
2Monoclonal AntibodiesIBA
06/2022 - 01/2019
2trilaciclibIBA
04/2022 - 11/2021
2ibrutinibIBA
04/2022 - 01/2017
2Carboplatin (JM8)FDA LinkGeneric
01/2022 - 07/2019
2Docetaxel (Taxotere)FDA Link
01/2022 - 11/2019
2talimogene laherparepvecIBA
12/2021 - 01/2019
2Lenalidomide (CC 5013)FDA Link
11/2021 - 05/2018
2Bendamustine HydrochlorideFDA Link
11/2021 - 08/2021
2Vincristine (Oncovin)FDA LinkGeneric
09/2021 - 01/2021
2Angiotensin Receptor AntagonistsIBA
06/2021 - 01/2021
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
06/2021 - 01/2021
2Antihypertensive Agents (Antihypertensives)IBA
01/2021 - 01/2017
2Paclitaxel (Taxol)FDA LinkGeneric
01/2021 - 07/2019
2Adrenal Cortex Hormones (Corticosteroids)IBA
10/2020 - 09/2017
2Dexamethasone (Maxidex)FDA LinkGeneric
03/2020 - 05/2018
2VildagliptinIBA
06/2019 - 12/2016
2Colony-Stimulating Factors (Colony Stimulating Factor)IBA
06/2019 - 06/2012
2Metformin (Glucophage)FDA LinkGeneric
06/2019 - 12/2016
2Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
06/2019 - 01/2018
2Phosphates (Orthophosphate)IBA
01/2019 - 12/2014
2Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2018 - 10/2018
2Cisplatin (Platino)FDA LinkGeneric
11/2018 - 10/2018
2Capecitabine (Xeloda)FDA Link
11/2018 - 10/2018
2Antineoplastic Agents (Antineoplastics)IBA
04/2015 - 01/2014

Therapy/Procedure

30Therapeutics
10/2022 - 10/2007
30Drug Therapy (Chemotherapy)
06/2022 - 01/2008
2Artificial Respiration (Mechanical Ventilation)
05/2022 - 01/2013
2Critical Care (Surgical Intensive Care)
05/2022 - 01/2022
2Decompression
04/2022 - 02/2022
2Stem Cell Transplantation
01/2016 - 01/2016
2Chelation Therapy (Therapy, Chelation)
05/2014 - 06/2011